Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NAVEED ALI RAJPER

Allopathic & Osteopathic Physicians Internal Medicine Interventional Cardiology

NPI
1114226354
CMS profile
5690027
Location
STATESVILLE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2024 · Entire year

$131,273.95

110 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NAVEED ALI RAJPER

NPI 1114226354 · CMS profile ID 5690027

Allopathic & Osteopathic Physicians / Internal Medicine / Interventional Cardiology

STATESVILLE, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1114226354?year=2024&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NAVEED ALI RAJPER, NPI 1114226354, CMS profile ID 5690027. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1114226354?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
APA 7
IndustryPayments. (2026). NAVEED ALI RAJPER, NPI 1114226354, CMS profile ID 5690027. General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1114226354?year=2024&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff.
Bluebook
NAVEED ALI RAJPER, NPI 1114226354, CMS profile ID 5690027, IndustryPayments, General Payments, PY2024; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 110 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/e6b17c6a-2534-4207-a4a1-6746a14911ff. https://industrypayments.org/provider/npi-1114226354?year=2024&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2024

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2024 · Physicians and non-physician practitioners · CMS publication 2026-06-30

110 matching records · $131,273.95 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 110 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 110.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Novo Nordisk Inc $125.0009/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096718920 CMS
Novo Nordisk Inc $6,006.2509/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096989672 CMS
E.R. Squibb & Sons, L.L.C. $20.6309/10/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101617649 CMS
Novartis Pharmaceuticals Corporation $11.0608/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251867 CMS
Novo Nordisk Inc $60.8508/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096619244 CMS
Novo Nordisk Inc $24.7908/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096892829 CMS
Novo Nordisk Inc $6,006.2508/27/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097406289 CMS
Novo Nordisk Inc $38.4408/27/2024 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097744120 CMS
iRhythm Technologies, Inc. $13.4008/20/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154054676 CMS
Kiniksa Pharmaceuticals International, plc $20.3108/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154875166 CMS
Novartis Pharmaceuticals Corporation $14.5208/13/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251863 CMS
Boston Scientific Corporation $6.7507/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092374737 CMS
Inspire Medical Systems, Inc. $17.2207/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148099089 CMS
PFIZER INC. $18.2707/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1131752314 CMS
Novo Nordisk Inc $329.5007/15/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097560825 CMS
Boston Scientific Corporation $20.2707/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092374741 CMS
Boston Scientific Corporation $143.0606/27/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1092374745 CMS
SCPHARMACEUTICALS INC. $26.8206/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1132282242 CMS
CVRx, Inc. $22.9806/12/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138419504 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.6106/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117876967 CMS
Novartis Pharmaceuticals Corporation $6.5806/06/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251859 CMS
Kiniksa Pharmaceuticals International, plc $20.7806/04/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154875136 CMS
Novo Nordisk Inc $6,260.5005/31/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1096979904 CMS
Novo Nordisk Inc $16.2205/30/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097343168 CMS
AngioDynamics, Inc. $23.0405/24/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095092395 CMS
Amgen Inc. $13.5505/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116039514 CMS
Novartis Pharmaceuticals Corporation $32.2305/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251851 CMS
CORDIS US CORP. $130.0705/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1145406641 CMS
AstraZeneca Pharmaceuticals LP $116.2105/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1104619790 CMS
Novartis Pharmaceuticals Corporation $15.0005/14/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251849 CMS
Merck Sharp & Dohme LLC $16.0705/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141913886 CMS
Novartis Pharmaceuticals Corporation $10.1005/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251845 CMS
W. L. Gore & Associates, Inc. $28.5305/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1148079528 CMS
Actelion Pharmaceuticals US, Inc. $17.0405/03/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1078898405 CMS
AngioDynamics, Inc. $16.0204/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1095092391 CMS
Novo Nordisk Inc $12.9804/23/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1097020611 CMS
Amgen Inc. $16.0304/18/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1116039507 CMS
Novartis Pharmaceuticals Corporation $14.4404/16/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251847 CMS
SANOFI-AVENTIS U.S. LLC $20.6504/11/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1139862498 CMS
Abbott Laboratories $31.1204/08/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124850954 CMS
Kiniksa Pharmaceuticals International, plc $18.1104/02/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154875102 CMS
E.R. Squibb & Sons, L.L.C. $18.3703/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1101617542 CMS
Novartis Pharmaceuticals Corporation $3.1403/28/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251841 CMS
Abbott Laboratories $133.1303/26/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1124850952 CMS
Merck Sharp & Dohme LLC $14.7103/21/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1141589762 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $15.5403/19/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1117876965 CMS
CVRx, Inc. $21.6902/29/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1138419502 CMS
Kiniksa Pharmaceuticals International, plc $24.4702/22/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1154875080 CMS
Novartis Pharmaceuticals Corporation $16.3302/15/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1087251839 CMS
Alnylam Pharmaceuticals Inc. $26.2602/09/2024 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1125833131 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $1,717.46 17
PY2020 $30.88 2
PY2021 $196.40 7
PY2022 $1,343.62 61
PY2023 $2,643.34 62
PY2024 $131,273.95 110
PY2025 $85,781.75 87

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $26,738.18 8

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Boehringer Ingelheim International GmbH $54.00 12/30/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634915
Principal investigator 1 Boehringer Ingelheim International GmbH $21.75 12/30/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634917
Principal investigator 1 Boehringer Ingelheim International GmbH $4.35 12/30/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634919
Principal investigator 1 Boehringer Ingelheim Pharma GmbH & Co.KG $6,676.96 11/20/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220994705
Principal investigator 1 AstraZeneca Pharmaceuticals LP $19,550.00 08/06/2025 Non-covered Recipient Entity
INNOVO RESEARCH LLC
A Phase III Randomised Doubleblind Study to Evaluate the Effect of Balcinrenone Dapagliflozin Compared with Dapagliflozin on the Risk of Heart Failure Events and Cardiovascular Death in Patients with Heart Failure and Impaired Kidney Function No dispute reported 06/30/2026 1185541372
Principal investigator 1 Boehringer Ingelheim International GmbH $34.98 07/28/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634909
Principal investigator 1 Boehringer Ingelheim International GmbH $359.64 07/28/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634911
Principal investigator 1 Boehringer Ingelheim International GmbH $36.50 07/28/2025 Non-covered Recipient Entity
Piedmont Healthcare PA Lake Norman Neurology
EASi-HF Reduced A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% No dispute reported 06/30/2026 1220634913